Kymera Therapeutics Stock Math Operators Price Series Multiplication

KYMR Stock

USD 79.03 1.53 1.97%

This math operators tool runs Price Series Multiplication operator and companion studies for Kymera Therapeutics and ACADIA Pharmaceuticals. The focus on relative price relationships between Kymera Therapeutics and ACADIA Pharmaceuticals helps organize trend, volatility, and risk context for Kymera Therapeutics and ACADIA Pharmaceuticals.

Symbols

Operator

The output start index for this execution was zero with a total number of output elements of sixty-one. Kymera Therapeutics Price Series Multiplication is a cross multiplication of Kymera Therapeutics price series and its benchmark/peer.

Kymera Therapeutics Technical Analysis Modules

Most technical analysis of Kymera Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kymera from various momentum indicators to cycle indicators. When you analyze Kymera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the bodys own natural protein degradation system. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts. Kymera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 160 people. Market structure and macro sensitivity help explain how Kymera Therapeutics behaves across regimes. Market sensitivity remains generally comparable to wider market conditions. Kymera Therapeutics has a market cap of 6.33 B, ROE of -25.78%.

Methodology

Unless otherwise specified, financial data for Kymera Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Kymera (USA Stocks:KYMR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Kymera Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Kymera Therapeutics is covered by 23 analysts. 11 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, RBC Capital Markets, Wells Fargo Securities, BMO Capital Markets, Stifel, Citigroup, UBS Investment Research, Bernstein Research, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Align your values with your investing style

Using Kymera Therapeutics inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Investor Favorites Invested few shares	Go
	FinTech Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Cash Cows Invested few shares	Go
	Momentum Invested few shares	Go
	Disruptive Technologies Invested few shares	Go
	Driverless Cars Invested few shares	Go
	Hedge Favorites Invested over 200 shares	Go
	Artificial Intelligence Invested few shares	Go
	Blockchain Invested few shares	Go
	Baby Boomer Prospects Invested over 20 shares	Go
	Macroaxis Picks Invested few shares	Go

Additional Tools for Kymera Stock Analysis

	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC